|
PhaseBio Pharmaceuticals
|
|
PhaseBio Pharmaceuticals is a specialty biopharmaceutical company developing a range of biopolymers for endocrine and metabolic disorders and cardiovascular disease. The company is located in Malvern, PA. As of March 2016, the company has raised $144 million in the funding rounds with the most recent Series C round of $40 million. The company was founded by Clay B. Thorp in 2002 and Jonathan Mow serves as CEO of the company. Operations The company's technology, elastin-like polypeptides, was initially developed by the team. The company is in the process of developing a treatment hyperglycemia, pulmonary arterial hypertension and Insumera. |
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
